End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.8 TWD | 0.00% | +9.45% | +39.00% |
Apr. 15 | Orient Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Orient Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 512M 15.86M | Sales 2023 | 890M 27.58M | Capitalization | 4.46B 138M |
---|---|---|---|---|---|
Net income 2022 | -28M -868K | Net income 2023 | 22M 682K | EV / Sales 2022 | 8.44 x |
Net Debt 2022 | 411M 12.73M | Net Debt 2023 | 604M 18.71M | EV / Sales 2023 | 5.69 x |
P/E ratio 2022 |
-136
x | P/E ratio 2023 |
200
x | Employees | 173 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 15.26% |
1 week | +9.45% | ||
Current month | +15.11% | ||
1 month | +24.38% | ||
3 months | +35.94% | ||
6 months | +40.05% | ||
Current year | +39.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chi Tai Chang
CEO | Chief Executive Officer | - | - |
Chia Ying Chen
DFI | Director of Finance/CFO | - | - |
Meng Lin Tsai
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Hung Tsai
CHM | Chairman | - | 08-01-14 |
Wei Chao Kao
BRD | Director/Board Member | - | - |
Kang Chi Chou
BRD | Director/Board Member | - | 19-06-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 27.8 | 0.00% | 119 934 |
24-05-21 | 27.8 | -0.54% | 97,480 |
24-05-20 | 27.95 | +3.33% | 258,002 |
24-05-17 | 27.05 | +0.19% | 59,173 |
24-05-16 | 27 | +2.66% | 63,316 |
End-of-day quote Taipei Exchange, May 21, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+39.00% | 192M | |
+37.76% | 723B | |
+32.22% | 598B | |
-2.05% | 364B | |
+20.55% | 331B | |
+3.85% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+8.30% | 169B |
- Stock Market
- Equities
- 4166 Stock